Innovative roadmaps for sustainable antimicrobial resistance interventions

Integrated strategies combining new commercial models, discovery platforms, genomic surveillance, clinical trials, and machine learning are key to accelerating diagnostics and therapeutics development against antimicrobial resistance globally.

This Wire brief sits within Fusion42's coverage of Biotech, Drug Discovery and AI Frontier Models.